MENU
GLYC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
GlycoMimetics (GLYC) Ownership - Who owns GlycoMimetics?
GlycoMimetics Inc is a clinical-stage biotechnology company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
9708 Medical Center Drive
Phone
+1 240 243-1201
Employees
35
Web
https://www.glycomimetics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
17.58M
P/E Ratio
N/A
Total Cash
14.39M
Projected Growth
N/A
Total Debt
262.13K
Revenue
10K
Risk (Beta)
2.06
Dividend Yield
N/A
Total Cash/Share
0.22
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GLYC
Capitalization
17.6M
P/E Ratio
N/A
Risk (Beta)
2.06
Dividend Yield
N/A
Total Cash
14.4M
Total Cash/Share
0.22
Total Debt
262K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
10K
ROE
N/A
Book Value
11.4M
P/B Ratio
3.17
Cash Flow
N/A
Earnings
-0.62
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
64.5K
Current Ratio
3.62
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-36.73M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-115.34
Shares Held By Institutions
3.56M
Shares Outstanding - Current
64.5M
Total Liabilities
4.32M
Total Volume MTD
N/A
Value
-1
Gain YTD
9.438
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs to treat inflammatory diseases and cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
9708 Medical Center Drive
Phone
+1 240 243-1201
Employees
35
Web
https://www.glycomimetics.com